2022
DOI: 10.1016/j.gore.2022.100938
|View full text |Cite
|
Sign up to set email alerts
|

Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review

Abstract: Highlights An iliac artery-enteric fistula is a rare but life-threatening condition that requires urgent treatment. We experienced a case of iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy. The patient underwent successful endovascular treatment with a covered stent-graft as a bridge to definitive open surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…The reported incidence of AEF is less than 1% and iliac artery-enteric fistulas make up less than .1% of all AEF. 2 Here, we present a patient in hemorrhagic shock secondary to an advanced colorectal malignancy without adjuvant therapies with local invasion of the right external iliac artery.…”
mentioning
confidence: 99%
“…The reported incidence of AEF is less than 1% and iliac artery-enteric fistulas make up less than .1% of all AEF. 2 Here, we present a patient in hemorrhagic shock secondary to an advanced colorectal malignancy without adjuvant therapies with local invasion of the right external iliac artery.…”
mentioning
confidence: 99%